| Dr Fabian Alexander Oechsle, MD | |
|
448 State Highway 248 Ste 140, Branson, MO 65616-3725 | |
| (417) 337-9808 | |
| Not Available |
| Full Name | Dr Fabian Alexander Oechsle |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 7 Years |
| Location | 448 State Highway 248 Ste 140, Branson, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972094225 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 2021025588 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercy Hospital Springfield | Springfield, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mercy Clinic Springfield Communities | 7416865845 | 922 |
| Mercy Clinic Springfield Communities | 7416865845 | 922 |
| Mercy Clinic Springfield Communities | 7416865845 | 922 |
| Mercy Hospital Springfield | 7416867593 | 103 |
News Archive
Osteologix, Inc. through its wholly owned Irish subsidiary Osteologix Limited and the Servier Research Group, the leading French independent pharmaceutical company, today announced that Osteologix has granted Servier an exclusive royalty bearing license to develop and commercialize NB S101 (strontium malonate) to treat post menopausal osteoporosis, other bone and joint disorders and dental indications worldwide, except in the U.S. NB S101 is an innovative molecule acting on both bone formation and bone resorption.
A.M. Best Co. is maintaining a negative outlook for health insurance companies. The driving factors are the struggles to grow revenue and the near-term impact from the implementation of health care reform. In 2009, the seasonally adjusted unemployment rate rose from 7.6% in January to a high of 10.2% in October and ended the year at 10.0%. The rising unemployment rate resulted in the loss of members due to layoffs/attrition (known as in-group disenrollment).
A new Cincinnati Children's Hospital Medical Center study shows that exposure to environmental tobacco smoke, even at extremely low levels, is associated with behavior problems in children and pre-teens.
Naurex Inc., a clinical-stage company developing innovative treatments to address unmet needs in psychiatry and neurology, today announced the completion of a $38 million Series B financing led by new investor Baxter Ventures.
Dr. Reddy's Laboratories announced today that it has launched Levofloxacin tablets, a bioequivalent generic version of LEVAQUIN tablets in the US market on June 20, 2011, following the approval by the United States Food & Drug Administration of Dr. Reddy's ANDA for Levofloxacin tablets.
› Verified 1 days ago
| Entity Name | Arkansas Emergency Staffing Solutions Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275774630 PECOS PAC ID: 3274681341 Enrollment ID: O20090501000014 |
News Archive
Osteologix, Inc. through its wholly owned Irish subsidiary Osteologix Limited and the Servier Research Group, the leading French independent pharmaceutical company, today announced that Osteologix has granted Servier an exclusive royalty bearing license to develop and commercialize NB S101 (strontium malonate) to treat post menopausal osteoporosis, other bone and joint disorders and dental indications worldwide, except in the U.S. NB S101 is an innovative molecule acting on both bone formation and bone resorption.
A.M. Best Co. is maintaining a negative outlook for health insurance companies. The driving factors are the struggles to grow revenue and the near-term impact from the implementation of health care reform. In 2009, the seasonally adjusted unemployment rate rose from 7.6% in January to a high of 10.2% in October and ended the year at 10.0%. The rising unemployment rate resulted in the loss of members due to layoffs/attrition (known as in-group disenrollment).
A new Cincinnati Children's Hospital Medical Center study shows that exposure to environmental tobacco smoke, even at extremely low levels, is associated with behavior problems in children and pre-teens.
Naurex Inc., a clinical-stage company developing innovative treatments to address unmet needs in psychiatry and neurology, today announced the completion of a $38 million Series B financing led by new investor Baxter Ventures.
Dr. Reddy's Laboratories announced today that it has launched Levofloxacin tablets, a bioequivalent generic version of LEVAQUIN tablets in the US market on June 20, 2011, following the approval by the United States Food & Drug Administration of Dr. Reddy's ANDA for Levofloxacin tablets.
› Verified 1 days ago
| Entity Name | Forrest City Emergency Physicians Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497080501 PECOS PAC ID: 0648319624 Enrollment ID: O20091204000091 |
News Archive
Osteologix, Inc. through its wholly owned Irish subsidiary Osteologix Limited and the Servier Research Group, the leading French independent pharmaceutical company, today announced that Osteologix has granted Servier an exclusive royalty bearing license to develop and commercialize NB S101 (strontium malonate) to treat post menopausal osteoporosis, other bone and joint disorders and dental indications worldwide, except in the U.S. NB S101 is an innovative molecule acting on both bone formation and bone resorption.
A.M. Best Co. is maintaining a negative outlook for health insurance companies. The driving factors are the struggles to grow revenue and the near-term impact from the implementation of health care reform. In 2009, the seasonally adjusted unemployment rate rose from 7.6% in January to a high of 10.2% in October and ended the year at 10.0%. The rising unemployment rate resulted in the loss of members due to layoffs/attrition (known as in-group disenrollment).
A new Cincinnati Children's Hospital Medical Center study shows that exposure to environmental tobacco smoke, even at extremely low levels, is associated with behavior problems in children and pre-teens.
Naurex Inc., a clinical-stage company developing innovative treatments to address unmet needs in psychiatry and neurology, today announced the completion of a $38 million Series B financing led by new investor Baxter Ventures.
Dr. Reddy's Laboratories announced today that it has launched Levofloxacin tablets, a bioequivalent generic version of LEVAQUIN tablets in the US market on June 20, 2011, following the approval by the United States Food & Drug Administration of Dr. Reddy's ANDA for Levofloxacin tablets.
› Verified 1 days ago
| Entity Name | Emergency Staffing Solutions Region Iii |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689967895 PECOS PAC ID: 3375721707 Enrollment ID: O20110706000473 |
News Archive
Osteologix, Inc. through its wholly owned Irish subsidiary Osteologix Limited and the Servier Research Group, the leading French independent pharmaceutical company, today announced that Osteologix has granted Servier an exclusive royalty bearing license to develop and commercialize NB S101 (strontium malonate) to treat post menopausal osteoporosis, other bone and joint disorders and dental indications worldwide, except in the U.S. NB S101 is an innovative molecule acting on both bone formation and bone resorption.
A.M. Best Co. is maintaining a negative outlook for health insurance companies. The driving factors are the struggles to grow revenue and the near-term impact from the implementation of health care reform. In 2009, the seasonally adjusted unemployment rate rose from 7.6% in January to a high of 10.2% in October and ended the year at 10.0%. The rising unemployment rate resulted in the loss of members due to layoffs/attrition (known as in-group disenrollment).
A new Cincinnati Children's Hospital Medical Center study shows that exposure to environmental tobacco smoke, even at extremely low levels, is associated with behavior problems in children and pre-teens.
Naurex Inc., a clinical-stage company developing innovative treatments to address unmet needs in psychiatry and neurology, today announced the completion of a $38 million Series B financing led by new investor Baxter Ventures.
Dr. Reddy's Laboratories announced today that it has launched Levofloxacin tablets, a bioequivalent generic version of LEVAQUIN tablets in the US market on June 20, 2011, following the approval by the United States Food & Drug Administration of Dr. Reddy's ANDA for Levofloxacin tablets.
› Verified 1 days ago
| Entity Name | Ess Hospitalist Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881967305 PECOS PAC ID: 6103085295 Enrollment ID: O20120308000726 |
News Archive
Osteologix, Inc. through its wholly owned Irish subsidiary Osteologix Limited and the Servier Research Group, the leading French independent pharmaceutical company, today announced that Osteologix has granted Servier an exclusive royalty bearing license to develop and commercialize NB S101 (strontium malonate) to treat post menopausal osteoporosis, other bone and joint disorders and dental indications worldwide, except in the U.S. NB S101 is an innovative molecule acting on both bone formation and bone resorption.
A.M. Best Co. is maintaining a negative outlook for health insurance companies. The driving factors are the struggles to grow revenue and the near-term impact from the implementation of health care reform. In 2009, the seasonally adjusted unemployment rate rose from 7.6% in January to a high of 10.2% in October and ended the year at 10.0%. The rising unemployment rate resulted in the loss of members due to layoffs/attrition (known as in-group disenrollment).
A new Cincinnati Children's Hospital Medical Center study shows that exposure to environmental tobacco smoke, even at extremely low levels, is associated with behavior problems in children and pre-teens.
Naurex Inc., a clinical-stage company developing innovative treatments to address unmet needs in psychiatry and neurology, today announced the completion of a $38 million Series B financing led by new investor Baxter Ventures.
Dr. Reddy's Laboratories announced today that it has launched Levofloxacin tablets, a bioequivalent generic version of LEVAQUIN tablets in the US market on June 20, 2011, following the approval by the United States Food & Drug Administration of Dr. Reddy's ANDA for Levofloxacin tablets.
› Verified 1 days ago
| Entity Name | Hospital Care Consultants Of Fordyce Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316497464 PECOS PAC ID: 5395024475 Enrollment ID: O20161112000042 |
News Archive
Osteologix, Inc. through its wholly owned Irish subsidiary Osteologix Limited and the Servier Research Group, the leading French independent pharmaceutical company, today announced that Osteologix has granted Servier an exclusive royalty bearing license to develop and commercialize NB S101 (strontium malonate) to treat post menopausal osteoporosis, other bone and joint disorders and dental indications worldwide, except in the U.S. NB S101 is an innovative molecule acting on both bone formation and bone resorption.
A.M. Best Co. is maintaining a negative outlook for health insurance companies. The driving factors are the struggles to grow revenue and the near-term impact from the implementation of health care reform. In 2009, the seasonally adjusted unemployment rate rose from 7.6% in January to a high of 10.2% in October and ended the year at 10.0%. The rising unemployment rate resulted in the loss of members due to layoffs/attrition (known as in-group disenrollment).
A new Cincinnati Children's Hospital Medical Center study shows that exposure to environmental tobacco smoke, even at extremely low levels, is associated with behavior problems in children and pre-teens.
Naurex Inc., a clinical-stage company developing innovative treatments to address unmet needs in psychiatry and neurology, today announced the completion of a $38 million Series B financing led by new investor Baxter Ventures.
Dr. Reddy's Laboratories announced today that it has launched Levofloxacin tablets, a bioequivalent generic version of LEVAQUIN tablets in the US market on June 20, 2011, following the approval by the United States Food & Drug Administration of Dr. Reddy's ANDA for Levofloxacin tablets.
› Verified 1 days ago
| Entity Name | Ess Of Fordyce Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821547977 PECOS PAC ID: 1254611601 Enrollment ID: O20161201001070 |
News Archive
Osteologix, Inc. through its wholly owned Irish subsidiary Osteologix Limited and the Servier Research Group, the leading French independent pharmaceutical company, today announced that Osteologix has granted Servier an exclusive royalty bearing license to develop and commercialize NB S101 (strontium malonate) to treat post menopausal osteoporosis, other bone and joint disorders and dental indications worldwide, except in the U.S. NB S101 is an innovative molecule acting on both bone formation and bone resorption.
A.M. Best Co. is maintaining a negative outlook for health insurance companies. The driving factors are the struggles to grow revenue and the near-term impact from the implementation of health care reform. In 2009, the seasonally adjusted unemployment rate rose from 7.6% in January to a high of 10.2% in October and ended the year at 10.0%. The rising unemployment rate resulted in the loss of members due to layoffs/attrition (known as in-group disenrollment).
A new Cincinnati Children's Hospital Medical Center study shows that exposure to environmental tobacco smoke, even at extremely low levels, is associated with behavior problems in children and pre-teens.
Naurex Inc., a clinical-stage company developing innovative treatments to address unmet needs in psychiatry and neurology, today announced the completion of a $38 million Series B financing led by new investor Baxter Ventures.
Dr. Reddy's Laboratories announced today that it has launched Levofloxacin tablets, a bioequivalent generic version of LEVAQUIN tablets in the US market on June 20, 2011, following the approval by the United States Food & Drug Administration of Dr. Reddy's ANDA for Levofloxacin tablets.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Fabian Alexander Oechsle, MD 448 State Highway 248 Ste 140, Branson, MO 65616-3725 Ph: (417) 337-9808 | Dr Fabian Alexander Oechsle, MD 448 State Highway 248 Ste 140, Branson, MO 65616-3725 Ph: (417) 337-9808 |
News Archive
Osteologix, Inc. through its wholly owned Irish subsidiary Osteologix Limited and the Servier Research Group, the leading French independent pharmaceutical company, today announced that Osteologix has granted Servier an exclusive royalty bearing license to develop and commercialize NB S101 (strontium malonate) to treat post menopausal osteoporosis, other bone and joint disorders and dental indications worldwide, except in the U.S. NB S101 is an innovative molecule acting on both bone formation and bone resorption.
A.M. Best Co. is maintaining a negative outlook for health insurance companies. The driving factors are the struggles to grow revenue and the near-term impact from the implementation of health care reform. In 2009, the seasonally adjusted unemployment rate rose from 7.6% in January to a high of 10.2% in October and ended the year at 10.0%. The rising unemployment rate resulted in the loss of members due to layoffs/attrition (known as in-group disenrollment).
A new Cincinnati Children's Hospital Medical Center study shows that exposure to environmental tobacco smoke, even at extremely low levels, is associated with behavior problems in children and pre-teens.
Naurex Inc., a clinical-stage company developing innovative treatments to address unmet needs in psychiatry and neurology, today announced the completion of a $38 million Series B financing led by new investor Baxter Ventures.
Dr. Reddy's Laboratories announced today that it has launched Levofloxacin tablets, a bioequivalent generic version of LEVAQUIN tablets in the US market on June 20, 2011, following the approval by the United States Food & Drug Administration of Dr. Reddy's ANDA for Levofloxacin tablets.
› Verified 1 days ago
Saima Rehman Qureshi, Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2715 W 76 Country Blvd Ste 103, Branson, MO 65616 Phone: 417-317-5318 | |
Roy Jack Gillispie, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 5136 Hwy 265, Branson, MO 65616 Phone: 417-338-0960 Fax: 417-338-0968 | |
Alok Shukla, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1140 W Highway 76, Branson, MO 65616 Phone: 417-317-5318 Fax: 417-763-3370 | |
Jeremy D Mabe, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1150 State Highway 248, Ste. 202, Branson, MO 65616 Phone: 417-348-8964 Fax: 417-336-0275 | |
Dr. Cody Stark Rogers, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 525 Branson Landing Blvd, Branson, MO 65616 Phone: 417-335-7128 Fax: 417-348-8007 | |
Sabera Shabnam, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 525 Branson Landing Blvd Ste 201a, Branson, MO 65616 Phone: 417-335-7128 Fax: 417-348-8007 | |
Dr. Lisa Requena, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 525 Branson Landing Blvd, Branson, MO 65616 Phone: 417-348-8646 Fax: 417-335-7529 |